Colorado Office of Economic Development and International Trade (OEDIT) has announced the newest recipients of state-funded Advanced Industries Accelerator Grants! Colorado BioScience Association congratulates our CBSA members and the honorees from across our state’s innovation ecosystem.

A total of 22 companies and 13 researchers, including eight life sciences companies and four researchers, from Colorado’s designated Advanced Industries will receive $7.3M in funding.

CBSA Congratulates Members Honored with Grants During the Current Cycle:

$250,000

$250,000

$250,000

$250,000

$250,000

Congratulations to Grant recipients at our partner academic and research institutions:

Raymond Goodrich

Juliette Hawa
Jay Hesselberth

Daniel Paredes

Congratulations to all grant recipients from Colorado’s life sciences ecosystem:

Mycobacteria Therapeutics
Kioga, Inc.
SideBy Care

About the Advanced Industries Accelerator Grant Program

The Advanced Industries Accelerator Grant Program, managed by Colorado Office of Economic Development and International Trade (OEDIT), is a critical source of non-dilutive funding for Colorado early-stage life sciences companies and organizations. It demonstrates a significant return on investment, delivering value back to the state through company creation and high-paying jobs.

The success metrics since program inception across all advanced industries include:

• $150.8M Awarded + $2.9B in Follow-On Capital 
• 830 Awards
• 5,036 New Jobs Created
• 5,223 Jobs Retained
• 124 New Companies Created
• 788 Patents Filed

CBSA is proud to support this vital source of funding for innovation-focused startups. The 2024-2025 Bioscience Colorado Magazine includes more information about the program’s impact and recent grantees.

CBSA Policy + Advocacy Update: Program Funding Cuts Due to Budget Shortfall

The Advanced Industries Accelerator Grant Program is a cornerstone of Colorado’s innovation ecosystem—providing critical nondilutive funding that helps early-stage life sciences companies grow, attract private investment, and bring breakthrough technologies to market.

During the 2025 legislative session, Colorado BioScience Association worked closely with our partners at the Colorado Office of Economic Development and International Trade (OEDIT), the Joint Budget Committee (JBC), and key legislators to protect both the grant and tax credit programs. Despite strong advocacy and broad recognition of the grant program’s high return on investment, two bills—SB25-264, which diverts $18.7M over two years to the General Fund, and SB25-225, which reduces the FY25-26 transfer from the Limited Gaming Fund from $5.5M to $1.84M—will significantly reduce available funding for the program. CBSA remains committed to working with partners and policymakers to restore full funding and preserve program dollars that support Colorado’s life sciences innovators.